Titre :
  • A new dendritic cell vaccine generated with interleukin-3 and interferon-beta induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients.
Auteur : Trakatelli, Myrto ; Toungouz Nevessignsky, Michel ; Blocklet, Didier ; Dodoo, Ygierne ; Gordower, Laurence ; Laporte, Marianne ; Vereecken, Pierre ; Sales, Francois ; Mortier, Laurent ; Mazouz, Naima ; Lambermont, Micheline ; Goldman, Serge ; Coulie, Pierre G ; Goldman, Michel ; Velu, Thierry
Informations sur la publication : Cancer immunology and immunotherapy, 55, 4, (page 469-474)
Statut de publication : Publié, 2006-04
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Antigens, Neoplasm -- immunology
CD8-Positive T-Lymphocytes
Cancer Vaccines -- immunology
Cell Culture Techniques
Cell Movement
Dendritic Cells -- immunology
Female
Humans
Immunotherapy -- methods
Interferon-beta -- immunology
Interleukin-3 -- immunology
Lymph Nodes -- immunology
Male
Melanoma -- immunology
Melanoma -- pathology
Melanoma -- therapy
Middle Aged
Skin Neoplasms -- immunology
Skin Neoplasms -- pathology
Skin Neoplasms -- therapy
Note : Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0340-7004 
info:doi/10.1007/s00262-005-0056-z
info:pmid/16133111